Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000185

Chief Scientific Officer sold 4,370 shares at $2.99 ($13,053)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kishimoto Takashi Kei Chief Scientific Officer 2021-12-10 Sale −4,370 $2.99 $13,053 199,769 D
Open-market sales · 4,370 sh · avg $2.99 · $13,053
Loading xslF345X03/wf-form4_163952018706703.xml…